<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Improving Outcomes for Drug Use–Associated Endocarditis

Default sub title

minute read

by Infectious Disease | March 7, 2022
placeholder

Outpatient parenteral antimicrobial therapy (OPAT) and partial oral antibiotic therapy regimens were as effective and less expensive than admitting patients with injection drug use–associated endocarditis for six weeks of IV antibiotics

Topics: Press Coverage